Canada markets close in 1 hour 14 minutes
  • S&P/TSX

    20,095.45
    -169.92 (-0.84%)
     
  • S&P 500

    4,227.91
    -55.83 (-1.30%)
     
  • DOW

    33,697.59
    -301.45 (-0.89%)
     
  • CAD/USD

    0.7698
    -0.0029 (-0.37%)
     
  • CRUDE OIL

    90.71
    +0.21 (+0.23%)
     
  • BTC-CAD

    27,794.79
    -2,635.19 (-8.66%)
     
  • CMC Crypto 200

    508.47
    -33.13 (-6.12%)
     
  • GOLD FUTURES

    1,762.60
    -8.60 (-0.49%)
     
  • RUSSELL 2000

    1,958.31
    -42.42 (-2.12%)
     
  • 10-Yr Bond

    2.9760
    +0.0960 (+3.33%)
     
  • NASDAQ

    12,709.06
    -256.29 (-1.98%)
     
  • VOLATILITY

    20.78
    +1.22 (+6.24%)
     
  • FTSE

    7,550.37
    +8.52 (+0.11%)
     
  • NIKKEI 225

    28,930.33
    -11.77 (-0.04%)
     
  • CAD/EUR

    0.7666
    +0.0011 (+0.14%)
     

YUMY CANDY ANNOUNCES PERMANENT LISTING WITH ONE OF CANADAS LEADING PHARMACY CHAINS LONDON DRUGS AND HAS DOUBLED ORDER VOLUMES AFTER SUCCESSFUL TRIAL LAUNCH

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

VANCOUVER, BC, June 27, 2022 /CNW/ - The Yumy Candy Company Inc., (CSE: TYUM) ("Yumy" or the "Company") Canada's first publicly traded low sugar, plant-based confectionery company, is pleased to announce that is has secured a permanent listing with London Drugs, one of Canada's leading retail pharmacy chains with 78 stores across Canada. In addition to pharmacy services, London Drugs locations also focus on the sales of non-perishable food items and a limited selection of grocery items. London Drugs Limited is owned by Georgia Main Food Group, formerly known as H.Y. Louie Co., a private family company established in 1903. It supplies and operates 34 grocery focused retail stores as well as the London Drugs chain.

Logo (CNW Group/Yumy Bear Goods Inc.)
Logo (CNW Group/Yumy Bear Goods Inc.)

The permanent listing was a result of a successful trial launch with select stores where the product sold through. Subsequently, the Company has received a series of orders double the purchase volumes of the initial orders. The purchase orders have significantly increased due to the increase in brand recognition and demand for the Yumy Candy brand in Western Canada.

The Strawberry Kiwi, Peach and Sour Watermelon vegan gummies were featured in two key promotions offered through the participating London Drugs locations. These include the Veganuary promotion and the Mindful Choices promotion, which the products had successful sell-throughs.

"The permanent listing and doubled purchase volumes with London Drugs have been a great accomplishment for the company. Having proven successful in established retail pharmacy chains will not only drive brand recognition, but also gain valuable customer trust in the product and in our brand. Over the last period, our company has gained significant traction with retailers and distributors alike and we expect more milestone achievements in the near future." States Erica Williams, CEO of Yumy Candy Company.

The products can currently be found in participating London Drugs retail stores and online through their e-commerce website.

The Yumy Candy is an affordable health-conscious low-sugar plant-based confectionery company based in Vancouver, British Columbia and it has developed a portfolio of healthier gelatine-free candies made from non-GMO ingredients with proprietary recipes. All of its products are free of gelatin, soy, gluten, nuts, dairy, eggs, sugar alcohols, artificial sweeteners and genetically modified organisms.

Cautionary Statement Regarding Forward-Looking Information

Except for the statements of historical fact, this news release contains "forward-looking information" within the meaning of the applicable securities legislation. The information in this news release about future plans and objectives of the Company, are forward-looking information. This forward-looking information is based on reasonable assumptions and estimates of management of the Company at the time it was made, and involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Such factors include, among others: general business, economic and social uncertainties; local and global market and economic uncertainties arising in respect of the COVID-19 pandemic; litigation, availability of key product ingredients, legislative, environmental and other judicial, regulatory, political and competitive developments; the ability to effectively expand manufacturing and production capacity; the ability to obtain retail partners to distribute Company products, the success of market initiatives and the ability to grow brand awareness; the ability to attract, maintain and expand relationships with key strategic vendors; our ability to predict consumer taste preferences; delay or failure to receive regulatory approvals; the sufficiency of our cash to meet liquidity needs; those additional risks set out in the Company's public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Accordingly, the forward-looking statements discussed in this release may not occur and could differ materially as a result of these known and unknown risk factors and uncertainties affecting the Company. Although the Company believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, the Company disclaims any intention or obligation to update or revise any forward- looking statement, whether as a result of new information, future events, or otherwise.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/yumy-candy-announces-permanent-listing-with-one-of-canadas-leading-pharmacy-chains-london-drugs-and-has-doubled-order-volumes-after-successful-trial-launch-301575996.html

SOURCE Yumy Bear Goods Inc.

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/27/c9913.html

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting